Cargando…
Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
Autor principal: | Martínez, Felipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054376/ https://www.ncbi.nlm.nih.gov/pubmed/33897838 http://dx.doi.org/10.15420/ecr.2020.38 |
Ejemplares similares
-
Assessment and management of peripheral arterial disease: what every cardiologist should know
por: Tran, Bao
Publicado: (2021) -
When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention
por: Iguchi, Moritake, et al.
Publicado: (2023) -
US CARDIOLOGIST AND PATIENT PERSPECTIVES ON COVID-19 TELEHEALTH PRACTICES FOR PATIENTS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM)
por: Mitter, Sumeet, et al.
Publicado: (2021) -
Cardiologist and Diabetologist crosstalk in the era of cardiovascular outcome trials of novel glucose-lowering drugs
por: Maranta, Francesco, et al.
Publicado: (2018) -
Effect of cardiac rehabilitation on cardiovascular risk factors in chronic heart failure patients
por: Mohammed, Haitham Galal, et al.
Publicado: (2018)